院前血浆随机试验中意外幸存者的特征分析
本研究基于院前航空医疗血浆试验(n=501),将严重创伤患者随机分为标准晶体液复苏或院前两单位血浆后标准液体复苏。建立广义线性模型估算死亡率,以预测死亡率>50%且存活至30天定义意外幸存者。共识别36例意外幸存者;与预期幸存者相比,意外幸存者更年轻、损伤更重、器官功能障碍和资源使用更差,且更可能接受院前血浆(67% vs 46%,p=0.031)。高预测死亡率未幸存者更多接受标准复苏(p<0.001);接受院前血浆的意外幸存者观察/预期死亡比低于标准复苏者。
要点
- 严重创伤患者院前接受两单位血浆后标准液体复苏,意外幸存者比例更高(67% vs 46%,p=0.031)。
- 高预测死亡率未幸存者更多接受标准晶体液复苏(p<0.001)。
- 接受院前血浆的意外幸存者观察/预期死亡比为0.56(0.33-0.84),标准复苏为1.0(0.73-1.32)。
- 意外幸存者更年轻(33岁 vs 47岁,p=0.013)、损伤更重(ISS 34 vs 18,p<0.001),器官功能障碍和住院资源使用更差。
- 模型预测死亡率优于损伤严重度评分或修订创伤评分参数,共识别36例意外幸存者。
适用人群与场景
- 严重创伤患者,由航空医疗转运,纳入院前航空医疗血浆试验随机分组(n=501)。
诊断标准与关键阈值
- 意外幸存者定义:模型预测死亡率大于50%且存活至30天。
处置流程与药物剂量
- 干预组:院前接受两单位血浆,随后标准液体复苏;对照组:标准晶体液复苏。
研究设计与关键结果
- 研究类型:院前航空医疗血浆随机试验的二次分析,样本量n=501。
- 主要结果:共识别36例意外幸存者;意外幸存者较预期幸存者更年轻(33岁[24,52] vs 47岁[32,59],p=0.013)、损伤更重(ISS 34[22,50] vs 18[10,27],p<0.001),器官功能障碍和住院资源使用更差,更可能接受院前血浆(67% vs 46%,p=0.031)。
- 高预测死亡率未幸存者更多接受标准复苏(p<0.001)。
- 接受院前血浆的意外幸存者观察/预期死亡比低于标准复苏者(O/E 0.56[0.33-0.84] vs 1.0[0.73-1.32])。
- 院前血浆幸存者数量(24例)超过模型预测幸存者数量(10例)(p<0.001)。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析;证据等级:治疗性证据III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,院前血浆与严重创伤后意外幸存者数量增加相关;基于早期损伤特征、生命体征和复苏措施的院前干预可能提高高预测死亡率患者的生存概率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prehospital plasma improves survival for severely injured trauma patients transported by air ambulance. We sought to characterize the unexpected survivors, patients who survived despite having high predicted mortality after traumatic injury.
METHODS: The Prehospital Air Medical Plasma trial randomized severely injured patients (n = 501) to receive either standard care (crystalloid) or two units of prehospital plasma followed by standard care fluid resuscitation. We built a generalized linear model to estimate patient mortality. Area under the receiver operating characteristic curve was used to evaluate model performance. We defined unexpected survivors as patients who had a predicted mortality greater than 50% and survived to 30 days. We characterized patient demographics, clinical features, and outcomes of the unexpected survivors. Observed to expected (O/E) ratios and Z-statistics were calculated using model-estimated mortality for each cohort.
RESULTS: Our model predicted mortality better than Injury Severity Score or Revised Trauma Score parameters and identified 36 unexpected survivors. Compared with expected survivors, unexpected survivors were younger (33 years [24, 52 years] vs. 47 years [32, 59 years], p = 0.013), were more severely injured (Injury Severity Score 34 [22, 50] vs. 18 [10, 27], p < 0.001), had worse organ dysfunction and hospital resource outcomes (multiple organ failure, intensive care unit, hospital length of stay, and ventilator days), and were more likely to receive prehospital plasma (67 vs. 46%, p = 0.031). Nonsurvivors with high predicted mortality were more likely to receive standard care resuscitation (p < 0.001). Unexpected survivors who received prehospital plasma had a lower observed to expected mortality than those that received standard care resuscitation (O/E 0.56 [0.33-0.84] vs. 1.0 [0.73-1.32]). The number of prehospital plasma survivors (24) exceeded the number of predicted survivors (n = 10) estimated by our model (p < 0.001).
CONCLUSION: Prehospital plasma is associated with an increase in the number of unexpected survivors following severe traumatic injury. Prehospital interventions may improve the probability of survival for injured patients with high predicted mortality based on early injury characteristics, vital signs, and resuscitation measures.
LEVEL OF EVIDENCE: Therapeutic Level III.
参考来源
- Gruen DS, Guyette FX, Brown JB, et al. Characterization of unexpected survivors following a prehospital plasma randomized trial. J Trauma Acute Care Surg. 2020. PMID: 32472902. doi:10.1097/TA.0000000000002816
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。